This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Galkina, E. Articles by Ley, K. Search for Related Content PubMed PubMed Citation Articles by Galkina, E. Articles by Ley, K. Related Collections Related Article

(Circulation Research. 2006;98:12.)
© 2006 American Heart Association, Inc.

Editorials

Double Jeopardy

How Soluble P-Selectin Activates Leukocytes in Peripheral Arterial Occlusive Disease

Elena Galkina, Klaus Ley

From the Robert M. Berne Cardiovascular Research Center (E.G., K.L.) and the Departments of Biomedical Engineering (E.G., K.L.) and Molecular Physiology and Biological Physics (K.L.), University of Virginia, Health Sciences Center, Charlottesville.

Correspondence to Klaus Ley, Cardiovascular Research Center, University of Virginia, P.O. Box 801394, Charlottesville, VA 22908. E-mail klausley@virginia.edu

See related article, pages 149–156

Key Words: soluble P-selectin • integrin • leukocyte • vascular disease

An extract of the first 250 words of the full text is provided, because this article has no abstract.

In this issue of Circulation Research, Woollard et al identify a critical role of pathologically elevated levels of soluble P-selectin (sP-selectin) found in the plasma of patients with peripheral arterial occlusive disease (PAOD) that promotes the activation of neutrophils and induces their adhesion to fibrinogen and platelet monolayers.¹ P-selectin is an inflammatory adhesion molecule expressed on activated platelets and endothelial cells.² During the last two decades, the role of inflammatory cells and adhesion molecules in the development and progression of vascular diseases has become apparent, and it is now recognized that many of the cellular and molecular events that underlie atherosclerotic vascular disease are inflammatory in nature.^3,4 One manifestation of atherosclerosis is PAOD, which is characterized by intermittent claudication and critical limb ischemia.⁵ The first case of intermittent claudication caused by arterial occlusive disease was described as early as 1831 by Jean Bouley, and a few years later Heinrich Erb proposed walking as a therapy for intermittent claudication⁶; however, the precise mechanism of development of PAOD as well as the optimal treatments of this disease still remain to be determined.

Numerous studies have identified soluble inflammatory markers including acute phase proteins and adhesion molecules as risk factors for cardiovascular disease, but it is unclear whether they play causative roles as active participants in the initiation and maintenance of the inflammation (mediators) or whether they merely indicate the existence of the disease (markers). Soluble P-selectin is elevated in patients with vascular disorders such as hypertension,⁷ hypercholesterolaemia,⁸ unstable angina,⁹ or . . . [Full Text of this Article]

Related Article:

Raised Plasma Soluble P-Selectin in Peripheral Arterial Occlusive Disease Enhances Leukocyte Adhesion

K.J. Woollard, D. Kling, S. Kulkarni, A.M. Dart, S. Jackson, and J. Chin-Dusting
Circ. Res. 2006 98: 149-156. [Abstract] [Full Text] [PDF]